Patents by Inventor Fritz Schückler

Fritz Schückler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9737488
    Abstract: The present invention pertains to a pharmaceutical composition comprising the compound of the formula (I) in a high concentration and at least one pharmaceutically acceptable excipient, the use of the composition for the treatment of hyper-proliferative diseases, such as cancer, either as a sole agent, or in combination with other anti-cancer therapies, and the process for preparing of said composition.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: August 22, 2017
    Assignee: Bayer HealthCare LLC
    Inventors: Fritz Schückler, Axel Wollenschläger
  • Publication number: 20120142741
    Abstract: This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of Formula I below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies.
    Type: Application
    Filed: November 23, 2011
    Publication date: June 7, 2012
    Inventor: Fritz Schueckler
  • Publication number: 20060078617
    Abstract: This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of Formula I below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies.
    Type: Application
    Filed: August 29, 2005
    Publication date: April 13, 2006
    Inventor: Fritz Schueckler
  • Patent number: 6511985
    Abstract: The present invention relates to the combination of the 3-hydroxy-3-methylglutaryl-coenzyme A inhibitor (HMG-CoA inhibitor) cerivastatin with fibrates and its use in the prophylaxis and treatment of disorders of lipid metabolism.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: January 28, 2003
    Assignee: Bayer Aktiengesellschaft
    Inventors: Joachim Ippen, Ulrike Schopen, Reiner Ziegler, Fritz Schückler
  • Patent number: 6503918
    Abstract: D-mannitol having a specific surface area of not less than about 1 m2/g is disclosed. The D-mannitol shows improved compressibility and is useful as an excipient.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: January 7, 2003
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tomohiro Yoshinari, Fritz Schueckler, Norbert Poellinger, Shinji Maegata
  • Publication number: 20020107420
    Abstract: D-mannitol having a specific surface area of not less than about 1 m2/g is disclosed. The D-mannitol shows improved compressibility and is useful as an excipient.
    Type: Application
    Filed: December 31, 2001
    Publication date: August 8, 2002
    Inventors: Tomohiro Yoshinari, Fritz Schueckler, Norbert Poellinger, Shinji Maegata
  • Patent number: 6235947
    Abstract: D-mannitol having a specific surface area of not less than about 1 m2/g is disclosed. The D-mannitol shows improved compressibility and is useful as an excipient.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: May 22, 2001
    Assignees: Takeda Chemical Industries, Ltd., Bayer AG
    Inventors: Tomohiro Yoshinari, Fritz Schueckler, Norbert Poellinger, Shinji Maegata
  • Publication number: 20010001106
    Abstract: D-mannitol having a specific surface area of not less than about 1 m2/g is disclosed. The D-mannitol shows improved compressibility and is useful as an excipient.
    Type: Application
    Filed: November 30, 2000
    Publication date: May 10, 2001
    Inventors: Tomohiro Yoshinari, Fritz Schueckler, Norbert Poellinger, Shinji Maegata